Data as of Jul 25
| +0.004 / +0.53%|
The 1 analysts offering 12-month price forecasts for Titan Pharmaceuticals Inc have a median target of 2.50, with a high estimate of 2.50 and a low estimate of 2.50. The median estimate represents a +231.13% increase from the last price of 0.76.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.